Modis Therapeutics is a biopharmaceutical company that develops and commercializes deoxynucleoside therapies for the treatment of genetic diseases.
Business Model:
Revenue: $7.1M
Employees: 11-50
Modis Therapeutics was acquired by
Zogenix.
The acquisition happend on 2019-08-26.
Details of the transaction were not public
Address: 409 13th Street
City: Oakland
State: CA
Zip: 94612
Country: US
Modis Therapeutics is a biopharmaceutical company that develops and commercializes deoxynucleoside therapies for the treatment of genetic diseases.
Contact Phone:
+15108068562
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2018 | Series A | $30M |
F-Prime Capital Partners Aceras Biomedical OrbiMed Advisors Osage University Partners |
10/2018 | Series A | 4 | $30M |
Aceras Life Sciences F-Prime Capital OrbiMed OUP (Osage University Partners) Aceras Life Sciences F-Prime Capital OrbiMed OUP (Osage University Partners) |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|